Nexalin Technology (NXL) Cash & Current Investments (2021 - 2026)

Nexalin Technology's (NXL) quarterly Cash & Current Investments came in at $2.7 million in Q1 2026, up 32.05% year-on-year from $2.1 million in Q1 2025, and down 55.87% quarter-over-quarter from $6.1 million in Q4 2025.

Nexalin Technology (NXL) Cash & Current Investments (2021 - 2026) Analysis & Trends

Nexalin Technology's Cash & Current Investments history runs 6 years deep, the most recent figure standing at $2.7 million for Q1 2026.

  • On a quarterly basis, Cash & Current Investments rose 32.05% year-over-year to $2.7 million in Q1 2026; TTM through Mar 2026 was $2.7 million, a 32.05% increase from a year earlier, with the FY2025 full-year figure at $6.1 million, up 76.35% from the prior year.
  • Cash & Current Investments retreated to $2.7 million in Q1 2026 per NXL's latest filing, from $6.1 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $10.6 million in Q1 2023 and bottomed at $848796.0 in Q2 2024.
  • The 5-year median for Cash & Current Investments is $5.8 million (2025), against an average of $5.5 million.
  • Across the five-year window, Cash & Current Investments jumped 956.84% in 2022 and tumbled 90.49% in 2024, its largest moves.
  • Year by year, Cash & Current Investments stood at $7.0 million in 2022, then tumbled by 57.84% to $2.9 million in 2023, then advanced by 18.03% to $3.5 million in 2024, then soared by 76.35% to $6.1 million in 2025, then plunged by 55.87% to $2.7 million in 2026.
  • Per Business Quant, the three latest NXL Cash & Current Investments figures stand at $2.7 million (Q1 2026), $6.1 million (Q4 2025), and $4.4 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn 7.30 Bn
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn 2.88 Bn
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn 9.22 Bn
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn 1.45 Bn
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn 3.67 Bn
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn 1.12 Bn
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn 2.29 Bn
8 Smith & Nephew 26.99 Bn 26.41 Bn - 577.00 Mn
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn 3.12 Bn
10 Nexalin Technology 9.07 Mn 6.36 Mn 13,133.00 2.71 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.71 Mn
Dec 31, 2025 6.14 Mn
Sep 30, 2025 4.35 Mn
Jun 30, 2025 5.79 Mn
Mar 31, 2025 2.05 Mn
Dec 31, 2024 3.48 Mn
Sep 30, 2024 9.02 Mn
Jun 30, 2024 848,796.00
Mar 31, 2024 3.20 Mn
Dec 31, 2023 2.95 Mn
Sep 30, 2023 7.15 Mn
Jun 30, 2023 8.93 Mn
Mar 31, 2023 10.60 Mn
Dec 31, 2022 6.99 Mn
Sep 30, 2022 7.86 Mn
Dec 31, 2021 661,778.00